T0007
Tacrolimus, CMIA
Test Details: Tacrolimus Chemiluminiscent microparticleimmunoassay (CMIA) is a delayed one-step immunoassay for the quantitative determination of tacrolimus in human whole blood using CMIA technology. The narrow therapeutic range of tacrolimus requires therapeutic drug monitoring to prevent transplant rejection and to minimize nephrotoxicity.
Category
Pre-test Information
Mention Time Of Drug Dose.
(Non Serum Separator Tube). TRF containing information regarding Specimen Type, Site, Clinical History Required and Clinician contact for notification.
Report Delivery
1 working day
Gender
All
Organ
Kidney
Tacrolimus, CMIA
3600
Most Searched Diagnostic Tests